US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
US6838477B2
(en)
*
|
1995-04-12 |
2005-01-04 |
President And Fellows Of Harvard College |
Lactacystin analogs
|
FR2758329B1
(fr)
*
|
1997-01-16 |
1999-02-12 |
Synthelabo |
Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
|
EP0979096B1
(en)
*
|
1997-02-15 |
2003-05-14 |
Millennium Pharmaceuticals, Inc. |
Treatment of infarcts through inhibition of nf-kappab
|
US6221888B1
(en)
*
|
1997-05-29 |
2001-04-24 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
WO1999015183A1
(en)
*
|
1997-09-25 |
1999-04-01 |
Proscript Inc. |
PROTEASOME INHIBITORS, UBIQUITIN PATHWAY INHIBITORS OR AGENTS THAT INTERFERE WITH THE ACTIVATION OF NF-λB VIA THE UBIQUITIN PROTEASOME PATHWAY TO TREAT INFLAMMATORY AND AUTOIMMUNE DISEASES
|
KR100458403B1
(ko)
*
|
1997-09-29 |
2004-11-26 |
포인트 써러퓨틱스, 인크. |
생체외 조혈세포의 자극방법
|
US6831057B2
(en)
*
|
1997-10-28 |
2004-12-14 |
The University Of North Carolina At Chapel Hill |
Use of NF-κB inhibition in combination therapy for cancer
|
CA2219867A1
(en)
*
|
1997-10-31 |
1999-04-30 |
Jiangping Wu |
The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
|
DE19802450A1
(de)
*
|
1998-01-23 |
1999-07-29 |
Hoechst Marion Roussel De Gmbh |
Ustilipide, Verfahren zu deren Herstellung sowie deren Verwendung
|
US6075150A
(en)
*
|
1998-01-26 |
2000-06-13 |
Cv Therapeutics, Inc. |
α-ketoamide inhibitors of 20S proteasome
|
US6617171B2
(en)
|
1998-02-27 |
2003-09-09 |
The General Hospital Corporation |
Methods for diagnosing and treating autoimmune disease
|
FR2779653B1
(fr)
|
1998-06-11 |
2002-12-20 |
Inst Nat Sante Rech Med |
Utilisation de composes modulateurs du proteasome en therapie
|
US6838436B1
(en)
*
|
1998-07-10 |
2005-01-04 |
Osteoscreen Inc. |
Inhibitors of proteasomal activity for stimulating bone growth
|
US6902721B1
(en)
|
1998-07-10 |
2005-06-07 |
Osteoscreen, Inc. |
Inhibitors of proteasomal activity for stimulating bone growth
|
US6462019B1
(en)
|
1998-07-10 |
2002-10-08 |
Osteoscreen, Inc. |
Inhibitors of proteasomal activity and production for stimulating bone growth
|
US6979697B1
(en)
*
|
1998-08-21 |
2005-12-27 |
Point Therapeutics, Inc. |
Regulation of substrate activity
|
EP0982317A1
(en)
*
|
1998-08-26 |
2000-03-01 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bivalent inhibitors of the proteasome
|
EP1123412B1
(en)
*
|
1998-10-20 |
2004-10-06 |
Millennium Pharmaceuticals, Inc. |
Method for monitoring proteasome inhibitor drug action
|
US6492333B1
(en)
|
1999-04-09 |
2002-12-10 |
Osteoscreen, Inc. |
Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors
|
US6890904B1
(en)
*
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
US6649593B1
(en)
*
|
1999-10-13 |
2003-11-18 |
Tularik Inc. |
Modulators of SREBP processing
|
CA2419238A1
(en)
*
|
2000-08-16 |
2002-02-21 |
University Of Alberta |
Non-pressurized methods for the preparation of conjugated solid supports for boronic acids
|
US6919382B2
(en)
|
2000-08-31 |
2005-07-19 |
The Governors Of The University Of Alberta |
Preparation and uses of conjugated solid supports for boronic acids
|
EP1430903A1
(de)
*
|
2000-10-12 |
2004-06-23 |
Viromics Gmbh |
Verwendung von Proteasome Hemmern zur Behandlung von Virus-Infektionen
|
EP1360189A1
(en)
|
2001-01-25 |
2003-11-12 |
Millennium Pharmaceuticals, Inc. |
Formulation of boronic acid compounds
|
US7112588B2
(en)
*
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
ES2278049T3
(es)
|
2001-05-21 |
2007-08-01 |
Alcon, Inc. |
Uso de inhibidores de proteasoma para tratar trastornos de ojo seco.
|
CN100415770C
(zh)
*
|
2001-05-30 |
2008-09-03 |
诺瓦提斯公司 |
2-{[n-(2-氨基-3-(杂芳基或芳基)丙酰基)-氨基酰基]-氨基}-烷基硼酸衍生物
|
JPWO2003033506A1
(ja)
*
|
2001-10-12 |
2005-02-03 |
杏林製薬株式会社 |
アミノボラン酸誘導体およびそれを含有するプロテアソーム阻害薬
|
WO2003033507A1
(fr)
*
|
2001-10-12 |
2003-04-24 |
Kyorin Pharmaceutical Co., Ltd. |
Derives d'acide benzylmalonique et inhibiteurs de proteasomes les contenant
|
EP1463719A2
(en)
|
2002-01-08 |
2004-10-06 |
Eisai Co., Ltd |
Eponemycin and epoxomicin analogs and uses thereof
|
US20040002479A1
(en)
*
|
2002-03-12 |
2004-01-01 |
Yihan Wang |
Peptide analogues and uses thereof
|
NZ534833A
(en)
*
|
2002-03-13 |
2006-07-28 |
Janssen Pharmaceutica Nv |
Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase (HDAC)
|
BR0307599A
(pt)
|
2002-03-13 |
2005-02-01 |
Janssen Pharmaceutica Nv |
Derivados de sulfonilamino como inibidores de histona deacetilase
|
ATE521592T1
(de)
*
|
2002-03-13 |
2011-09-15 |
Janssen Pharmaceutica Nv |
Histone-deacetylase-inhibitoren
|
DE60321548D1
(de)
*
|
2002-03-13 |
2008-07-24 |
Janssen Pharmaceutica Nv |
Carbonylamino- derivativate als neue inhibitoren von histone deacetylase
|
DE10391147D2
(de)
*
|
2002-04-05 |
2005-02-17 |
Viromics Gmbh |
Mittel zur Behandlung von Flaviviridae-Infektionen
|
US7514579B2
(en)
*
|
2002-06-13 |
2009-04-07 |
Johns Hopkins University |
Boronic chalcone derivatives and uses thereof
|
EP1578434A2
(en)
*
|
2002-07-09 |
2005-09-28 |
Point Therapeutics, Inc. |
Methods and compositions relating to isoleucine boroproline compounds
|
JP2005539028A
(ja)
*
|
2002-08-14 |
2005-12-22 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
乳腺炎の処置のためのnf−カッパbインヒビターの使用
|
US7112572B2
(en)
*
|
2002-09-09 |
2006-09-26 |
Trigen Limited |
Multivalent metal salts of boronic acids
|
US20060084592A1
(en)
*
|
2002-09-09 |
2006-04-20 |
Trigen Limited |
Peptide boronic acid inhibitors
|
US20050176651A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Trigen Limited |
Peptide boronic acids useful in making salts thereof
|
US20050282757A1
(en)
*
|
2002-09-09 |
2005-12-22 |
Trigen Limited |
Peptide boronic acid compounds useful in anticoagulation
|
US20050119226A1
(en)
*
|
2003-09-09 |
2005-06-02 |
Trigen Limited |
Methods for synthesizing organoboronic compounds and products thereof
|
EP1466916B1
(en)
*
|
2002-09-09 |
2007-10-24 |
Trigen Limited |
Peptide boronic acids useful in making salts thereof
|
KR20050057175A
(ko)
*
|
2002-09-20 |
2005-06-16 |
알콘, 인코퍼레이티드 |
안구건조증 치료용 사이토카인 합성 저해제의 용도
|
EP1581629B1
(en)
|
2002-12-06 |
2015-04-01 |
Millennium Pharmaceuticals, Inc. |
Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
|
CN100341880C
(zh)
*
|
2003-02-13 |
2007-10-10 |
上海仁虎制药股份有限公司 |
新型硼酸或硼酸酯类化合物、制备方法及在药学上的应用
|
WO2005007211A2
(en)
*
|
2003-07-03 |
2005-01-27 |
Medtronic Vascular Inc. |
Medical devices with proteasome inhibitors for the treatment of restenosis
|
US7223745B2
(en)
*
|
2003-08-14 |
2007-05-29 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
US7576206B2
(en)
|
2003-08-14 |
2009-08-18 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
CA2542886A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Neelima M. Bhat |
Enhanced b cell cytotoxicity of cdim binding antibody
|
US20060052390A1
(en)
*
|
2003-12-24 |
2006-03-09 |
Scios, Inc. |
Treatment of multiple myeloma by p38 MAP kinase and proteasome inhibition
|
WO2005082348A2
(en)
*
|
2004-02-23 |
2005-09-09 |
Trustees Of Tufts College |
Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism
|
GB0405272D0
(en)
*
|
2004-03-09 |
2004-04-21 |
Trigen Ltd |
Compounds
|
US7371875B2
(en)
*
|
2004-03-12 |
2008-05-13 |
Miikana Therapeutics, Inc. |
Cytotoxic agents and methods of use
|
AU2016202747B2
(en)
*
|
2004-03-30 |
2017-11-23 |
Millennium Pharmaceuticals, Inc. |
Synthesis of boronic ester and acid compounds
|
RS51983B
(en)
|
2004-03-30 |
2012-02-29 |
Millennium Pharmaceuticals Inc. |
SYNTHESIS OF ORGANOBORIC ACID AND ORGANOBORIC ACID COMPOUNDS
|
CN103554222A
(zh)
|
2004-04-15 |
2014-02-05 |
欧尼斯治疗公司 |
用于抑制蛋白酶体酶的化合物
|
US8198270B2
(en)
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
JP5108509B2
(ja)
|
2004-05-10 |
2012-12-26 |
プロテオリックス, インコーポレイテッド |
酵素阻害のための化合物
|
JP2008504292A
(ja)
|
2004-06-24 |
2008-02-14 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド |
免疫増強用の化合物
|
AU2005267093B2
(en)
|
2004-07-23 |
2009-10-01 |
Nuada Llc |
Peptidase inhibitors
|
JP4948403B2
(ja)
|
2004-07-28 |
2012-06-06 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストン・デアセチラーゼの新インヒビターとしての置換インドリルアルキルアミノ誘導体
|
EP2100899A3
(en)
|
2004-10-20 |
2009-09-30 |
Proteolix, Inc. |
Compounds for proteasome enzyme inhibition
|
DK1814913T3
(en)
|
2004-11-05 |
2015-09-28 |
Univ Leland Stanford Junior |
ANTIBODY-INDUCED CELL membrane damage.
|
TW200618820A
(en)
*
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
US8017395B2
(en)
|
2004-12-17 |
2011-09-13 |
Lifescan, Inc. |
Seeding cells on porous supports
|
US20070098685A1
(en)
*
|
2005-01-19 |
2007-05-03 |
Brand Stephen J |
Methods and kits to treat chronic inflammatory immune diseases by administering a proteasome inhibitor and an interleukin 2 receptor agonist
|
JP5475235B2
(ja)
|
2005-01-21 |
2014-04-16 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
CA2595749A1
(en)
*
|
2005-01-27 |
2006-08-03 |
Research Development Foundation |
Combination therapy with triterpenoid compounds and proteasome inhibitors
|
US7468383B2
(en)
*
|
2005-02-11 |
2008-12-23 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
US7767657B2
(en)
|
2005-02-16 |
2010-08-03 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
CA2597982C
(en)
*
|
2005-02-16 |
2014-07-08 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
WO2006099261A2
(en)
*
|
2005-03-11 |
2006-09-21 |
The University Of North Carolina At Chapel Hill |
Potent and specific immunoproteasome inhibitors
|
US20060252740A1
(en)
*
|
2005-04-29 |
2006-11-09 |
Johnson Robert G Jr |
Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either in combination with a proteasome inhibitor
|
CA2605272C
(en)
|
2005-05-18 |
2013-12-10 |
Janssen Pharmaceutica N.V. |
Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
|
AU2006202209B2
(en)
*
|
2005-05-27 |
2011-04-14 |
Lifescan, Inc. |
Amniotic fluid derived cells
|
US9074189B2
(en)
*
|
2005-06-08 |
2015-07-07 |
Janssen Biotech, Inc. |
Cellular therapy for ocular degeneration
|
WO2007002972A2
(en)
*
|
2005-07-06 |
2007-01-11 |
Biodevelops Pharma Entwicklung Gmbh |
Use of a compound for enhancing the expression of membrane proteins on the cell surface
|
US7531517B2
(en)
|
2005-08-10 |
2009-05-12 |
4Sc Ag |
Inhibitors of cancer cell, T-cell and keratinocyte proliferation
|
EP1752467A1
(en)
|
2005-08-10 |
2007-02-14 |
4Sc Ag |
Inhibitors of cancer cell, t-cell and keratinocyte proliferation
|
US20070059382A1
(en)
*
|
2005-09-09 |
2007-03-15 |
Board Of Regents, Univ. And Comm. College System Of Nevada... |
Medical treatment of breast cancer with boric acid materials
|
NZ595196A
(en)
|
2005-11-09 |
2013-03-28 |
Proteolix Inc |
Peptide-based compounds for enzyme inhibition
|
EP1956908A2
(en)
*
|
2005-12-08 |
2008-08-20 |
Cytokinetics, Inc. |
Certain compositions and methods of treatment
|
JP5247470B2
(ja)
*
|
2006-01-19 |
2013-07-24 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
|
PL1981874T3
(pl)
*
|
2006-01-19 |
2009-10-30 |
Janssen Pharmaceutica Nv |
Pochodne aminofenylowe jako nowe inhibitory deacetylazy histonowej
|
EP1979327A1
(en)
*
|
2006-01-19 |
2008-10-15 |
Janssen Pharmaceutica, N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
AU2007206950B2
(en)
*
|
2006-01-19 |
2012-02-02 |
Janssen Pharmaceutica N.V. |
Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
PE20070978A1
(es)
*
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
SI2719388T1
(sl)
|
2006-02-16 |
2019-06-28 |
Anacor Pharmaceuticals, Inc. |
Majhne molekule, polnjene z borom, kot učinkovine proti vnetjem
|
AR060358A1
(es)
*
|
2006-04-06 |
2008-06-11 |
Novartis Vaccines & Diagnostic |
Quinazolinas para la inhibicion de pdk 1
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
DE102006026464A1
(de)
|
2006-06-01 |
2007-12-06 |
Virologik Gmbh Innovationszentrum Medizintechnik Und Pharma |
Pharmazeutische Zusammensetzung zur Behandlung von Virusinfektionen und / oder Tumorerkrankungen durch Inhibition der Proteinfaltung und des Proteinabbaus
|
WO2007143600A2
(en)
*
|
2006-06-05 |
2007-12-13 |
Incyte Corporation |
Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
|
PL2041158T3
(pl)
|
2006-06-19 |
2013-08-30 |
Onyx Therapeutics Inc |
Peptydowe epoksyketony do hamowania proteasomu
|
EP2066328A2
(en)
*
|
2006-09-15 |
2009-06-10 |
Janssen Pharmaceutica N.V. |
Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors
|
PL2066327T3
(pl)
*
|
2006-09-15 |
2013-03-29 |
Janssen Pharmaceutica Nv |
Inhibitory deacetylaz histonowych o działaniu skojarzonym na deacetylazy histonowe klasy I oraz klasy IIB w kombinacji z inhibitorami proteasomu
|
WO2008044045A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
EP2073803B1
(en)
|
2006-10-12 |
2018-09-19 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
CA2606634A1
(en)
*
|
2006-12-08 |
2008-06-08 |
Centenary Institute Of Cancer Medicine And Cell Biology |
Assay for response to proteasome inhibitors
|
JO3396B1
(ar)
*
|
2007-06-20 |
2019-10-20 |
Anacor Pharmaceuticals Inc |
جزيئات صغيرة تحتوي على البورون
|
US9080145B2
(en)
|
2007-07-01 |
2015-07-14 |
Lifescan Corporation |
Single pluripotent stem cell culture
|
EP2610336A1
(en)
|
2007-07-31 |
2013-07-03 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
JP2010535708A
(ja)
|
2007-08-03 |
2010-11-25 |
ビオマリン アイジーエー リミテッド |
デュシェンヌ型筋ジストロフィーの治療のための薬物併用
|
EA034601B1
(ru)
*
|
2007-08-06 |
2020-02-25 |
Милленниум Фармасьютикалз, Инк. |
Способ получения бороновых кислот
|
US7442830B1
(en)
*
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
AU2016253697A1
(en)
*
|
2007-08-06 |
2016-11-24 |
Millennium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
WO2009020448A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Millennium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
JP2010539183A
(ja)
*
|
2007-09-12 |
2010-12-16 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
ボルテゾミブおよびその生成のためのプロセス
|
US20090076031A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bortezomib
|
PL2207791T5
(pl)
|
2007-10-04 |
2020-07-27 |
Onyx Therapeutics, Inc. |
Krystaliczne peptydo- epoksy ketonowe inhibitory proteazy i synteza keto-epoksydów Aminokwasowych
|
US7838673B2
(en)
*
|
2007-10-16 |
2010-11-23 |
Millennium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
US20090110688A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Georg Fertig |
Combination therapy of type ii anti-cd20 antibody with a proteasome inhibitor
|
US9062290B2
(en)
|
2007-11-27 |
2015-06-23 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells
|
CN101220048B
(zh)
*
|
2007-12-14 |
2012-08-15 |
江苏先声药物研究有限公司 |
ZnCl2催化下的蒎烷二醇酯的制备方法
|
PE20091523A1
(es)
|
2007-12-20 |
2009-10-29 |
Novartis Ag |
Derivados de tiazol como inhibidores de la enzima fosfatidilinositol 3-cinasa (pi3k)
|
KR20190057164A
(ko)
|
2008-02-21 |
2019-05-27 |
얀센 바이오테크 인코포레이티드 |
세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물
|
MX2010009765A
(es)
|
2008-03-06 |
2013-07-12 |
Anacor Pharmaceuticals Inc |
Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
|
EP2285384A4
(en)
*
|
2008-05-12 |
2012-04-25 |
Anacor Pharmaceuticals Inc |
BORN SMALL MOLECULES
|
EP2730579A1
(en)
*
|
2008-06-17 |
2014-05-14 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
CA2729121C
(en)
|
2008-06-30 |
2019-04-09 |
Centocor Ortho Biotech Inc. |
Differentiation of pluripotent stem cells
|
CN101638414B
(zh)
*
|
2008-07-30 |
2014-01-08 |
江苏先声药物研究有限公司 |
肽硼酸及其酯类化合物、制备方法及其用途
|
US20100028307A1
(en)
*
|
2008-07-31 |
2010-02-04 |
O'neil John J |
Pluripotent stem cell differentiation
|
EP2348863A4
(en)
*
|
2008-09-04 |
2012-03-07 |
Anacor Pharmaceuticals Inc |
BORN SMALL MOLECULES
|
WO2010028005A1
(en)
|
2008-09-04 |
2010-03-11 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
AR075090A1
(es)
*
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
US9493489B2
(en)
*
|
2008-10-15 |
2016-11-15 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as anti-protozoal agents
|
AP2011005690A0
(en)
|
2008-10-21 |
2011-06-30 |
Onyx Therapeutics Inc |
Combination therapy with peptide epoxyketones.
|
CA2742268C
(en)
|
2008-10-31 |
2020-02-18 |
Centocor Ortho Biotech Inc. |
Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
|
MX2011004563A
(es)
|
2008-10-31 |
2011-06-01 |
Centocor Ortho Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas al linaje endocrino pancreatico.
|
KR101837080B1
(ko)
|
2008-11-20 |
2018-03-09 |
얀센 바이오테크 인코포레이티드 |
마이크로-캐리어 상의 만능 줄기 세포 배양
|
CA2744227C
(en)
*
|
2008-11-20 |
2018-10-02 |
Centocor Ortho Biotech Inc. |
Methods and compositions for cell attachment and cultivation on planar substrates
|
CN101747354B
(zh)
*
|
2008-12-04 |
2014-08-13 |
江苏先声药物研究有限公司 |
一类β氨基酸组成的二肽硼酸及其酯类化合物、制备方法及其用途
|
EP2378886A4
(en)
*
|
2008-12-17 |
2012-08-29 |
Anacor Pharmaceuticals Inc |
(S) -3-Aminomethyl-7- (3-hydroxypropoxy) -3H-benzo [c] [1,2] oxaborole-1-OL-POLYMORPHS
|
KR20110114562A
(ko)
|
2009-01-09 |
2011-10-19 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
보르테조밉 함유 약학적 조성물
|
EP2399129B1
(en)
|
2009-02-20 |
2015-11-25 |
Michael P. Lisanti |
A method of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm
|
CN102369011A
(zh)
|
2009-03-12 |
2012-03-07 |
健泰科生物技术公司 |
用于治疗造血恶性肿瘤的磷酸肌醇3-激酶抑制剂化合物与化学治疗剂的组合
|
WO2010106135A1
(en)
|
2009-03-20 |
2010-09-23 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Combined use for the treatment of ovarian carcinoma
|
TWI504598B
(zh)
|
2009-03-20 |
2015-10-21 |
Onyx Therapeutics Inc |
結晶性三肽環氧酮蛋白酶抑制劑
|
CA2756193A1
(en)
|
2009-03-24 |
2010-09-30 |
Janssen Pharmaceutica Nv |
Biomarkers for assessing peripheral neuropathy response to treatment with a proteasome inhibitor
|
EA201171195A8
(ru)
*
|
2009-03-30 |
2014-08-29 |
Серулин Фарма Инк. |
Конъюгаты, частицы, композиции "полимер-агент" и способы их применения
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
MX2011012538A
(es)
*
|
2009-05-27 |
2012-02-08 |
Cephalon Inc |
Terapia de combinacion para el tratamiento del mieloma multiple.
|
EP2280016A1
(en)
|
2009-07-27 |
2011-02-02 |
LEK Pharmaceuticals d.d. |
New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
|
AU2010261710A1
(en)
|
2009-06-19 |
2012-01-19 |
Lek Pharmaceuticals D.D. |
Process for hydrogenation of halogenoalkenes without dehalogenation
|
CN101928329B
(zh)
|
2009-06-19 |
2013-07-17 |
北京大学 |
三肽硼酸(酯)类化合物、其制备方法和应用
|
EP2270019A1
(en)
|
2009-06-19 |
2011-01-05 |
LEK Pharmaceuticals d.d. |
New synthetic route for the preparation of alpha-amino boronic esters
|
US8293753B2
(en)
|
2009-07-02 |
2012-10-23 |
Novartis Ag |
Substituted 2-carboxamide cycloamino ureas
|
DE102009027754A1
(de)
|
2009-07-15 |
2011-05-05 |
Schubert, Ulrich, Dr. |
Verfahren zur Hemmung der Reifung von dendritischen Zellen
|
KR102058901B1
(ko)
|
2009-07-20 |
2019-12-24 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 분화
|
GB2485112B
(en)
*
|
2009-07-20 |
2014-02-26 |
Janssen Biotech Inc |
Differentiation of human embryonic stem cells
|
WO2011011349A2
(en)
|
2009-07-20 |
2011-01-27 |
Centocor Ortho Biotech Inc. |
Differentiation of human embryonic stem cells
|
BR112012001987A2
(pt)
*
|
2009-07-28 |
2015-09-01 |
Anacor Pharmaceuticals Inc |
Composto, combinação, formulação farmacêutica, uso de um composto, uma combinação ou um sal farmaceuticamente aceitável dos mesmos, e, métodos para tratar uma infecção bacteriana, para matar ou inibir o crescimento de uma bactéria, e para inibir uma beta-lactamase.
|
AP4039A
(en)
|
2009-08-14 |
2017-02-28 |
Daitao Chen |
Boron-containing small molecules as antiprotozoal agents
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
WO2011022337A1
(en)
*
|
2009-08-19 |
2011-02-24 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as antiprotozoal agents
|
JP5567136B2
(ja)
|
2009-09-08 |
2014-08-06 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
4−置換ピリジン−3−イル−カルボキサミド化合物及び使用方法
|
US20110124597A1
(en)
*
|
2009-09-25 |
2011-05-26 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
EP2305285A1
(en)
|
2009-09-29 |
2011-04-06 |
Julius-Maximilians-Universität Würzburg |
Means and methods for treating ischemic conditions
|
ES2624644T3
(es)
|
2009-10-01 |
2017-07-17 |
Janssen Pharmaceutica, N.V. |
Inhibidores de proteasoma para el tratamiento de cáncer
|
WO2011049971A1
(en)
|
2009-10-20 |
2011-04-28 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as antiprotozoal agents
|
US20110212918A1
(en)
*
|
2009-11-11 |
2011-09-01 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
JP5919196B2
(ja)
|
2009-11-13 |
2016-05-18 |
オニキス セラピューティクス, インク.Onyx Therapeutics, Inc. |
転移抑制のためのペプチドエポキシケトンの使用
|
AU2010341530B2
(en)
|
2009-12-22 |
2016-03-10 |
Cephalon, Inc. |
Proteasome inhibitors and processes for their preparation, purification and use
|
WO2011079017A2
(en)
|
2009-12-23 |
2011-06-30 |
Centocor Ortho Biotech Inc. |
Differentiation of human embryonic stem cells
|
SG181822A1
(en)
|
2009-12-23 |
2012-08-30 |
Centocor Ortho Biotech Inc |
Differentiation of human embryonic stem cells
|
US20110178287A1
(en)
|
2010-01-19 |
2011-07-21 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
WO2011094450A1
(en)
|
2010-01-27 |
2011-08-04 |
Anacor Pharmaceuticals, Inc |
Boron-containing small molecules
|
EP2542667A4
(en)
|
2010-03-01 |
2013-07-31 |
Janssen Biotech Inc |
PROCESS FOR CLEANING CELLS OBTAINED FROM PLURIPOTENTIAL STEM CELLS
|
BR112012022060A2
(pt)
*
|
2010-03-01 |
2018-05-08 |
Onyx Therapeutics Inc |
composto para a inibição de imunoproteassoma
|
US8263578B2
(en)
|
2010-03-18 |
2012-09-11 |
Innopharma, Inc. |
Stable bortezomib formulations
|
RU2529800C2
(ru)
*
|
2010-03-18 |
2014-09-27 |
ИННОФАРМА, Инк. |
Стабильные составы бортезомиба
|
AP2012006482A0
(en)
|
2010-03-19 |
2012-10-31 |
Anacor Pharmacueticals Inc |
Boron-containing small molecules as anti-protozoalagent
|
EP2550362B1
(en)
|
2010-03-25 |
2017-01-04 |
Oregon Health&Science University |
Cmv glycoproteins and recombinant vectors
|
JP5933523B2
(ja)
*
|
2010-03-31 |
2016-06-08 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
1−アミノ−2−シクロプロピルエチルボロン酸の誘導体
|
AU2013204868B2
(en)
*
|
2010-03-31 |
2016-10-13 |
Millennium Pharmaceuticals, Inc. |
Derivatives of 1-amino-2-cyclopropylethylboronic acid
|
NZ602872A
(en)
|
2010-04-07 |
2014-05-30 |
Onyx Therapeutics Inc |
Crystalline peptide epoxyketone immunoproteasome inhibitor
|
CN101812026B
(zh)
*
|
2010-04-12 |
2013-08-28 |
亚邦医药股份有限公司 |
一种硼替佐米的合成方法
|
JP5801378B2
(ja)
|
2010-04-19 |
2015-10-28 |
ニーキ ファーマ インコーポレイテッド |
プロテアソーム阻害剤およびガリウム錯体を用いた併用療法
|
WO2011139379A2
(en)
|
2010-05-06 |
2011-11-10 |
Duke University |
A method of treating patients undergoing protein replacement therapy, gene replacement therapy, or other therapeutic modalities
|
KR101903562B1
(ko)
|
2010-05-12 |
2018-10-02 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 분화
|
EA035193B1
(ru)
|
2010-05-18 |
2020-05-14 |
Серулин Фарма Инк. |
Композиции и способы лечения аутоиммунных и других заболеваний
|
AR082418A1
(es)
|
2010-08-02 |
2012-12-05 |
Novartis Ag |
Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
|
CN103154239B
(zh)
|
2010-08-31 |
2018-05-15 |
詹森生物科技公司 |
人胚胎干细胞的分化
|
EP2611909B1
(en)
|
2010-08-31 |
2018-01-17 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
US9181528B2
(en)
|
2010-08-31 |
2015-11-10 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
JP5952280B2
(ja)
|
2010-09-07 |
2016-07-13 |
アナコール ファーマシューティカルズ,インコーポレーテッド |
細菌感染治療用のベンゾオキサボロール誘導体
|
US9126997B1
(en)
|
2010-09-07 |
2015-09-08 |
Northwestern University |
Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma
|
EP2624818B1
(en)
|
2010-10-05 |
2017-04-05 |
Fresenius Kabi USA, LLC |
Bortezomib formulations stabilised with boric acid
|
ES2548256T3
(es)
|
2010-10-14 |
2015-10-15 |
Synthon Bv |
Proceso para la preparación de bortezomib y los intermedios para el proceso
|
UY33883A
(es)
|
2011-01-31 |
2012-08-31 |
Novartis Ag |
Novedosos derivados heterocíclicos
|
TW201309303A
(zh)
|
2011-03-03 |
2013-03-01 |
Cephalon Inc |
用於治療狼瘡的蛋白酶體抑制劑
|
WO2012135528A2
(en)
|
2011-03-29 |
2012-10-04 |
Texas Tech University System |
Galectin-3c combination therapy for human cancer
|
TWI533885B
(zh)
|
2011-03-31 |
2016-05-21 |
Nanocarrier Co Ltd |
And a pharmaceutical composition comprising a block copolymer containing a boronic acid compound
|
CA2832109C
(en)
|
2011-06-10 |
2021-07-06 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
WO2012177835A1
(en)
*
|
2011-06-22 |
2012-12-27 |
Cephalon, Inc. |
Proteasome inhibitors and processes for their preparation, purification and use
|
US8481655B2
(en)
|
2011-07-27 |
2013-07-09 |
Wacker Chemical Corporation |
Copper complexes of amino-functional organosilicon compounds and their use
|
DK2742356T3
(en)
|
2011-08-11 |
2016-05-23 |
Janssen Pharmaceutica Nv |
CANCER TREATMENT PREDICTORS
|
WO2013021032A1
(en)
|
2011-08-11 |
2013-02-14 |
Janssen Pharmaceutica Nv |
Histone deacetylase inhibitors in combination with proteasome inhibitors and dexamethasone
|
US8927593B2
(en)
|
2011-08-19 |
2015-01-06 |
Glaxo Group Limited |
Benzofuran compounds for the treatment of hepatitis C virus infections
|
EP2753334B1
(en)
|
2011-08-30 |
2022-10-19 |
Trustees Of Tufts College |
Fap-activated proteasome inhibitors for treating solid tumors
|
AU2012216792A1
(en)
|
2011-09-12 |
2013-03-28 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
WO2013061305A1
(en)
|
2011-10-28 |
2013-05-02 |
Novartis Ag |
Novel purine derivatives and their use in the treatment of disease
|
CN104302180B
(zh)
|
2011-10-28 |
2017-05-17 |
米伦纽姆医药公司 |
对nedd8活化酶(nae)抑制剂的反应的生物标记
|
US9920373B2
(en)
|
2011-11-11 |
2018-03-20 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
WO2013071163A2
(en)
|
2011-11-11 |
2013-05-16 |
Millennium Pharamaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
US9114177B2
(en)
|
2011-11-17 |
2015-08-25 |
The University Of Tokyo |
Block copolymer having phenylboronic acid group introduced therein, and use thereof
|
CN105143446B
(zh)
|
2011-12-22 |
2020-11-03 |
詹森生物科技公司 |
人胚胎干细胞分化成单一激素胰岛素阳性细胞
|
US9732101B2
(en)
|
2012-01-18 |
2017-08-15 |
Wisconsin Alumni Research Foundation |
Bioreversible boronates for delivery of molecules into cells
|
US9234048B2
(en)
|
2012-01-18 |
2016-01-12 |
Wisconsin Alumni Research Foundation |
Boronate-mediated delivery of molecules into cells
|
WO2013112601A1
(en)
|
2012-01-24 |
2013-08-01 |
Millennium Pharmaceuticals, Inc. |
Methods of treatment of cancer
|
US10085987B2
(en)
|
2012-01-27 |
2018-10-02 |
Thomas Jefferson University |
MCT protein inhibitor-related prognostic and therapeutic methods
|
CA2863714C
(en)
|
2012-02-08 |
2022-07-05 |
Igm Biosciences, Inc. |
Cdim binding proteins and uses thereof
|
CA2866135A1
(en)
|
2012-03-02 |
2014-09-06 |
Dr. Reddy's Laboratories Limited |
Pharmaceutical compositions comprising boronic acid compounds
|
CN104160018A
(zh)
|
2012-03-07 |
2014-11-19 |
詹森生物科技公司 |
用于扩增和维持多能干细胞的成分确定的培养基
|
CA2784240C
(en)
|
2012-03-27 |
2014-07-08 |
Innopharma, Inc. |
Stable bortezomib formulations
|
US10213432B2
(en)
|
2012-05-16 |
2019-02-26 |
Novartis Ag |
Dosage regimen for a PI-3 kinase inhibitor
|
RU2018108850A
(ru)
|
2012-06-08 |
2019-02-26 |
Янссен Байотек, Инк. |
Дифференцировка эмбриональных стволовых клеток человека в панкреатические эндокринные клетки
|
EP2679596B1
(en)
|
2012-06-27 |
2017-04-12 |
International Aids Vaccine Initiative |
HIV-1 env glycoprotein variant
|
JP2015524394A
(ja)
|
2012-07-09 |
2015-08-24 |
オニキス セラピューティクス, インク.Onyx Therapeutics, Inc. |
ペプチドエポキシケトンプロテアーゼ阻害剤のプロドラッグ
|
JP2013006855A
(ja)
*
|
2012-09-03 |
2013-01-10 |
Millennium Pharmaceuticals Inc |
プロテアソーム阻害剤
|
RU2015112190A
(ru)
*
|
2012-09-11 |
2016-11-10 |
Сипла Лимитед |
Способ получения бортезомиба
|
CA2886783A1
(en)
|
2012-10-01 |
2014-04-10 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods to predict response to inhibitors and uses thereof
|
WO2014072985A1
(en)
|
2012-11-06 |
2014-05-15 |
Natco Pharma Limited |
Novel boronic acid derivatives as anti cancer agents
|
CA2891822A1
(en)
|
2012-11-16 |
2014-05-22 |
Shilpa Medicare Limited |
Crystalline bortezomib process
|
WO2014097306A1
(en)
|
2012-12-21 |
2014-06-26 |
Natco Pharma Limited |
Stable and pure polymorphic form of bortezomib
|
WO2014106141A1
(en)
|
2012-12-31 |
2014-07-03 |
Janssen Biotech, Inc. |
Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
|
DK2938724T3
(da)
|
2012-12-31 |
2020-12-14 |
Janssen Biotech Inc |
Dyrkning af humane embryonale stamceller ved luft-væskegrænsefladen til differentiering til endokrine pankreasceller
|
US10138465B2
(en)
|
2012-12-31 |
2018-11-27 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 regulators
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
RS59411B1
(sr)
|
2013-03-13 |
2019-11-29 |
Forma Therapeutics Inc |
Derivati 2-hidroksi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etan-1-ona i srodna jedinjenja kao inhibitori sintaze masnih kiselina (fasn) za lečenje kancera
|
CA2909519A1
(en)
|
2013-04-16 |
2014-10-23 |
Cipla Limited |
Process for the preparation of bortezomib mannitol ester
|
EP2986290A4
(en)
|
2013-04-19 |
2017-01-04 |
Thomas Jefferson University |
Caveolin-1 related methods for treating glioblastoma with temozolomide
|
US9603775B2
(en)
|
2013-04-24 |
2017-03-28 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
WO2015003146A1
(en)
|
2013-07-03 |
2015-01-08 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
US20150065381A1
(en)
|
2013-09-05 |
2015-03-05 |
International Aids Vaccine Initiative |
Methods of identifying novel hiv-1 immunogens
|
MX2016003979A
(es)
|
2013-10-03 |
2016-06-15 |
Millennium Pharm Inc |
Metodo para profilaxis o tratamiento de lupus eritematoso sistemico y/o nefritis lupica.
|
EP2873423B1
(en)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
CN104586776B
(zh)
*
|
2013-10-30 |
2017-05-17 |
扬子江药业集团上海海尼药业有限公司 |
以硼替佐米为活性成分的制剂及其制备方法
|
JP6468562B2
(ja)
*
|
2013-11-21 |
2019-02-13 |
国立大学法人北海道大学 |
プロテアソーム阻害性化合物
|
EP3077823B1
(en)
|
2013-12-05 |
2019-09-04 |
The Broad Institute, Inc. |
Compositions and methods for identifying and treating cachexia or pre-cachexia
|
JP2016539149A
(ja)
|
2013-12-06 |
2016-12-15 |
ノバルティス アーゲー |
アルファ−アイソフォーム選択的ホスファチジルイノシトール3−キナーゼ阻害剤の投薬レジメン
|
US10167311B2
(en)
|
2014-02-03 |
2019-01-01 |
Ohio State Innovation Foundation |
Boronic acid esters and pharmaceutical formulations thereof
|
EP2910557A1
(en)
*
|
2014-02-20 |
2015-08-26 |
Ikerchem, S.L. |
Enantiopure tetrasubstituted pyrrolidines as scaffolds for proteasome inhibitors and medicinal applications thereof
|
US10993960B1
(en)
|
2014-05-08 |
2021-05-04 |
Kawasaki Institute Of Industrial Promotion |
Pharmaceutical composition
|
JP6588969B2
(ja)
|
2014-05-16 |
2019-10-09 |
ヤンセン バイオテツク,インコーポレーテツド |
膵内分泌細胞内のmafa発現を強化するための小分子の使用
|
KR102481856B1
(ko)
|
2014-05-20 |
2022-12-26 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
일차 암 치료법 후 사용하기 위한 붕소-함유 프로테아좀 저해제
|
WO2016022955A1
(en)
|
2014-08-07 |
2016-02-11 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
MX2017004043A
(es)
*
|
2014-10-01 |
2017-07-04 |
Merck Patent Gmbh |
Derivados de acido boronico.
|
WO2016110870A1
(en)
|
2015-01-07 |
2016-07-14 |
Emcure Pharmaceuticals Limited |
Pharmaceutical composition of bortezomid
|
MA41505A
(fr)
|
2015-02-11 |
2017-12-19 |
Millennium Pharm Inc |
Nouvelle forme cristalline d'un inhibiteur de protéasome
|
WO2016146516A1
(en)
|
2015-03-17 |
2016-09-22 |
Leon-Nanodrugs Gmbh |
Nanoparticles comprising a stabilized boronic acid compound
|
EP3069730A3
(en)
|
2015-03-20 |
2017-03-15 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
EP3072901A1
(en)
|
2015-03-23 |
2016-09-28 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
WO2016184793A1
(en)
|
2015-05-15 |
2016-11-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for treating a patient with vegfr inhibitor-resistant metastatic renal cell carcinoma
|
US10144761B2
(en)
|
2015-06-19 |
2018-12-04 |
Hanlin Scientific Inc. |
Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
|
EP3120836A1
(de)
|
2015-07-22 |
2017-01-25 |
Stada Arzneimittel Ag |
Gebrauchsfertige bortezomib-lösung
|
EP3120837A1
(de)
|
2015-07-22 |
2017-01-25 |
Stada Arzneimittel Ag |
Verfahren zur herstellung einer bortezomibester-lösung
|
CN106478700B
(zh)
*
|
2015-08-26 |
2020-12-29 |
杭州雷索药业有限公司 |
硼基取代的苯胺类蛋白激酶抑制剂
|
CN106588965A
(zh)
*
|
2015-10-15 |
2017-04-26 |
北京大学 |
脲拟肽硼酸化合物及其药物组合物、制备方法和用途
|
AU2016347881A1
(en)
|
2015-11-02 |
2018-05-10 |
Novartis Ag |
Dosage regimen for a phosphatidylinositol 3-kinase inhibitor
|
WO2017106196A1
(en)
|
2015-12-14 |
2017-06-22 |
The Broad Institute, Inc. |
Compositions and methods for treating cardiac dysfunction
|
CN107151255A
(zh)
*
|
2016-03-06 |
2017-09-12 |
复旦大学 |
硼酸类化合物及其制备方法和用途
|
CN107151254A
(zh)
*
|
2016-03-06 |
2017-09-12 |
复旦大学 |
一种作为20s蛋白酶体抑制剂的硼酸类化合物及其制备方法
|
MA45479A
(fr)
|
2016-04-14 |
2019-02-20 |
Janssen Biotech Inc |
Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
|
US11447506B2
(en)
|
2016-05-09 |
2022-09-20 |
Anacor Pharmaceuticals, Inc. |
Crystal forms of crisaborole in free form and preparation method and use thereof
|
CN106008572B
(zh)
*
|
2016-05-23 |
2018-08-17 |
成都千禧莱医药科技有限公司 |
一类二肽硼酸化合物及制备方法和用途
|
CN114685453A
(zh)
|
2016-06-21 |
2022-07-01 |
奥瑞恩眼科有限责任公司 |
杂环脯氨酰胺衍生物
|
JP7164521B2
(ja)
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|
JP6681284B2
(ja)
*
|
2016-06-23 |
2020-04-15 |
信越化学工業株式会社 |
糖アルコール化合物の金属低減方法
|
JP6223508B2
(ja)
*
|
2016-06-27 |
2017-11-01 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
プロテアソーム阻害剤
|
WO2018038687A1
(en)
|
2016-08-22 |
2018-03-01 |
Mustafa Nevzat Ilaç Sanayii A.Ş. |
Pharmaceutical formulations comprising a bortezomib-cyclodextrin complex
|
WO2018060833A1
(en)
|
2016-09-27 |
2018-04-05 |
Novartis Ag |
Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
|
WO2018073790A1
(en)
|
2016-10-20 |
2018-04-26 |
Pfizer Inc. |
Therapeutic particles with peptide boronic acid or boronate ester compounds and methods of making and using same
|
US11584733B2
(en)
|
2017-01-09 |
2023-02-21 |
Shuttle Pharmaceuticals, Inc. |
Selective histone deacetylase inhibitors for the treatment of human disease
|
US11034667B2
(en)
|
2017-01-09 |
2021-06-15 |
Shuttle Pharmaceuticals, Inc. |
Selective histone deacetylase inhibitors for the treatment of human disease
|
WO2018150386A1
(en)
|
2017-02-17 |
2018-08-23 |
Fresenius Kabi Oncology Ltd. |
An improved process for the preparation of boronic acid esters
|
CA3054572A1
(en)
|
2017-02-28 |
2018-09-07 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
CN117338932A
(zh)
|
2017-08-23 |
2024-01-05 |
科智生命科学公司 |
自身免疫性病症的治疗中的免疫蛋白酶体抑制剂和免疫抑制剂
|
JP2020533382A
(ja)
|
2017-09-14 |
2020-11-19 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
癌の組合せ治療
|
JP2018024694A
(ja)
*
|
2017-10-03 |
2018-02-15 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
プロテアソーム阻害剤
|
PL3710457T3
(pl)
*
|
2017-11-16 |
2023-02-20 |
Principia Biopharma Inc. |
Inhibitory immunoproteasomu
|
MA50906A
(fr)
|
2017-11-16 |
2020-09-23 |
Principia Biopharma Inc |
Inhibiteurs d'immunoprotéasome
|
US10537585B2
(en)
|
2017-12-18 |
2020-01-21 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising dexamethasone
|
CA3087565A1
(en)
|
2018-01-09 |
2019-07-18 |
Shuttle Pharmaceuticals, Inc. |
Selective histone deacetylase inhibitors for the treatment of human disease
|
US20210106522A1
(en)
|
2018-01-29 |
2021-04-15 |
Cognos Therapeutics, Inc. |
Intratumoral delivery of bortezomib
|
WO2019178438A1
(en)
|
2018-03-15 |
2019-09-19 |
Abbvie Inc. |
Abbv-621 in combination with anti-cancer agents for the treatment of cancer
|
US11243207B2
(en)
|
2018-03-29 |
2022-02-08 |
Mayo Foundation For Medical Education And Research |
Assessing and treating cancer
|
WO2020092395A1
(en)
|
2018-10-29 |
2020-05-07 |
Forma Therapeutics, Inc. |
SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE
|
CN109824756B
(zh)
*
|
2019-03-19 |
2022-03-22 |
山东大学 |
含有4-(苯磺酰基)哌嗪-2-酮的苯丙氨酸衍生物及其制备方法与应用
|
CN114437119A
(zh)
*
|
2020-10-30 |
2022-05-06 |
苏州开拓药业股份有限公司 |
一种c-Myc蛋白抑制剂及其制备方法和用途
|
JP2023553011A
(ja)
*
|
2020-12-02 |
2023-12-20 |
ホフマン・テクノロジーズ・エルエルシー |
非ヒト哺乳動物においてがんを調節するための組成物および方法
|
TW202237143A
(zh)
*
|
2020-12-10 |
2022-10-01 |
南韓商Lg化學股份有限公司 |
酸(Boronic Acid)化合物
|
US11964993B2
(en)
|
2021-07-03 |
2024-04-23 |
Shilpa Pharma Lifesciences Limited |
Crystalline bortezomib process
|
EP4134083A1
(en)
|
2021-08-12 |
2023-02-15 |
Extrovis AG |
Pharmaceutical compositions of bortezomib
|
CN113957441B
(zh)
*
|
2021-10-29 |
2024-01-02 |
光华科学技术研究院(广东)有限公司 |
蚀刻液及其制备方法和应用
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023220641A2
(en)
|
2022-05-11 |
2023-11-16 |
Juno Therapeutics, Inc. |
Methods and uses related to t cell therapy and production of same
|
WO2024097905A1
(en)
|
2022-11-02 |
2024-05-10 |
Celgene Corporation |
Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy
|